Neurological Paraneoplastic Syndromes in most Common Cancers in Poland
DOI:
https://doi.org/10.12775/JEHS.2024.64.006Keywords
neoplasm, neurological manifestations, paraneoplastic syndromes, oncological vigilanceAbstract
INTRODUCTION: Paraneoplastic Neurological Syndromes (PNS) represent a heterogeneous group of diseases associated with the presence of neoplasm. The appearance of PNS can precede cancer diagnosis. The estimated frequency amongst cancer patients is about 1%. Malignant tumors represent a serious health problem and are the second leading cause of death in Poland. The aim of this study is to collect information about PNS focusing on cancers mostly diagnosed in Polish adults.
REVIEW METHODS: The analysis was conducted based on information regarding PNS gathered from PubMed and Google Scholar within the context of selected cancers.
THE STATE OF KNOWLEDGE: PNS develop from an autoimmune reaction in which onconeural antibodies are produced. The recent classification divides PNS to high risk, indicating a likely paraneoplastic origin and intermediate risk, if this association is less evident. Diagnosis is difficult and usually relies on exclusion methods. The symptoms described are non-specific and the diagnostic process may require the involvement of various specialists. The main approaches include cancer treatment, especially tumor removal and immunotherapy, which in certain may prove to be effective.
SUMMARY: Although PNS is relatively rare, its detectability has recently increased.
Many syndromes are especially associated with lung cancer (mainly small cell carcinoma).
Breast and prostate cancers have also shown associations with certain syndromes.
They can present with nonspecific symptoms related to different organ systems.
Awareness and understanding of this phenomenon can be helpful amongst many specialists.
References
Wojciechowska U, Barańska K, Michałek I, Olasek P, Miklewska M, Didkowska, J. Malignant neoplasms in Poland in 2020. Warszawa: Maria Skłodowska-Curie National Research Institute of Oncology; 2022. Polish.
ECIS - European Cancer Information System, https://ecis.jrc.ec.europa.eu , access: 7.11.2023
Henry K. Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment. Semin Diagn Pathol. 2019;36(4):204-210. https://doi.org/10.1053/j.semdp.2019.01.002
Rafał Stec, Marta Smoter, Andrzej Deptała, Oncology, Gdańsk, AsteriaMed, 2021; 332-333. Polish.
Thapa B, Mahendraker N, Ramphul K. Paraneoplastic Syndromes. In: StatPearls. Treasure Island (FL): StatPearls Publishing; March 31, 2023.
Pelosof, L. C., & Gerber, D. E. (2010). Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clinic proceedings, 85(9), 838–854. https://doi.org/10.4065/mcp.2010.0099
Jiraporn Jitprapaikulsan, Pritikanta Paul, Smathorn Thakolwiboon, Shivam Om Mittal, Sean J Pittock, Divyanshu Dubey, Paraneoplastic neurological syndrome: an evolving story, Neuro-Oncology Practice, Volume 8, Issue 4, August 2021, Pages 362–374, https://doi.org/10.1093/nop/npab002
Gilligan, M., McGuigan, C. & McKeon, A. Paraneoplastic Neurologic Disorders. Curr Neurol Neurosci Rep 23, 67–82 (2023). https://doi.org/10.1007/s11910-023-01250-w
Binks S, Uy C, Honnorat J, Irani SR. Paraneoplastic neurological syndromes: a practical approach to diagnosis and management. Pract Neurol. 2022;22(1):19-31. https://doi.org/10.1136/practneurol-2021-003073
Jayarangaiah A, Lui F, Theetha Kariyanna P. Lambert-Eaton Myasthenic Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; October 23, 2023.
Graus F, Vogrig A, Muñiz-Castrillo S, et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1014. Published 2021 May 18. https://doi.org/10.1212/NXI.0000000000001014
Soomro Z, Youssef M, Yust-Katz S, Jalali A, Patel AJ, Mandel J. Paraneoplastic syndromes in small cell lung cancer. J Thorac Dis. 2020;12(10):6253-6263. https://doi.org/10.21037/jtd.2020.03.88
Chiu D, Rhee J, Gonzalez Castro LN. Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes. Antibodies (Basel). 2023;12(3):50. Published 2023 Jul 31. https://doi.org/10.3390/antib12030050
Tirthani E, Said MS, Smith RG, Jadhav N, Shanina E. Paraneoplastic Encephalomyelitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; June 25, 2023.
Maiorca C, Moret F, Martines V, et al. Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Lung Adenocarcinoma: A Case Report. Front Med (Lausanne). 2022;8:743798. Published 2022 Jan 17.https://doi.org/10.3389/fmed.2021.743798
Altabakhi IW, Babiker HM. Paraneoplastic Limbic Encephalitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 10, 2022.
Aly R, Emmady PD. Paraneoplastic Cerebellar Degeneration. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 4, 2023.
Muranova A, Shanina E. Stiff Person Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 10, 2023.
Zoccarato M, Grisold W, Grisold A, Poretto V, Boso F, Giometto B. Paraneoplastic Neuropathies: What's New Since the 2004 Recommended Diagnostic Criteria. Front Neurol. 2021;12:706169. Published 2021 Oct 1. https://doi.org/10.3389/fneur.2021.706169
Cleaver J, James R, Rice CM. Rhomboencephalitis [published online ahead of print, 2020 Dec 8]. Pract Neurol. 2020; practneurol-2020-002680. https://doi.org/10.1136/practneurol-2020-002680
Jubelt B, Mihai C, Li TM, Veerapaneni P. Rhombencephalitis / brainstem encephalitis. Curr Neurol Neurosci Rep. 2011;11(6):543-552. https://doi.org/10.1007/s11910-011-0228-5
Rojas-Marcos I, Rousseau A, Keime-Guibert F, et al. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Medicine. 2003;82:216–23.
Blaes F. Paraneoplastic brain stem encephalitis. Curr Treat Options Neurol. 2013;15(2):201-209. https://doi.org/10.1007/s11940-013-0221-1
Nguyen L, Wang C. Anti-NMDA Receptor Autoimmune Encephalitis: Diagnosis and Management Strategies. Int J Gen Med. 2023;16:7-21. Published 2023 Jan 4. https://doi.org/10.2147/IJGM.S397429
Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–165. doi:10.1016/S1474-4422(12)70310-1
Paciolla L, Galli G, Vecchio D, Padelli S, Comi C, Cantello R, Virgilio E. Isolated Myelopathy in Occult Breast Carcinoma with Negative Paraneoplastic Antibodies: A Case Report of a Rare Condition. Sclerosis. 2023; 1(1):60-66. https://doi.org/10.3390/sclerosis1010007
Basal E, Zalewski N, Kryzer TJ, et al. Paraneoplastic neuronal intermediate filament autoimmunity. Neurology. 2018;91(18):e1677-e1689. https://doi.org/10.1212/WNL.0000000000006435
Flanagan EP, McKeon A, Lennon VA, et al. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology. 2011;76(24):2089-2095. https://doi.org/10.1212/WNL.0b013e31821f468f
McKinley W, Hills A, Sima A. Posterior cord syndrome: Demographics and rehabilitation outcomes. J Spinal Cord Med. 2021;44(2):241-246. https://doi.org/10.1080/10790268.2019.1585135
Bosch A, Stauffer ES, Nickel VL.. Incomplete traumatic quadriplegia: a ten-year review. JAMA. 1971;216:473–478. doi: 10.1001/jama.1971.03180290049006
Ropper A and Samuels M.. Adams and Victor’s Principles of Neurology. 8th ed. New York: McGraw Hill Medical; 2005. p. 129–143.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Julia Piątkiewicz, Maria Krzyżanowska, Karen Głogowska, Mikołaj Wojtas, Mateusz Sztybór, Monika Maleszewska, Aleksandra Żmijewska, Gabriela Nowak, Marcin Kapica, Wojciech Kopacz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 445
Number of citations: 0